My Newsfeed

logo
The Baseline US
19 Jan 2025
2024  was a banner year for the S&P500. Will 2025 be different?

The rise of the S&P 500 index is supposed to reflect the performance of a diversified group of stocks and sectors. But since the 2010s, it's been more like a Big 7 index, with its rise driven by the most powerful, primarily tech companies. In 2024, the Magnificent 7 -Apple, NVIDIA, Microsoft, Alphabet, Amazon, Meta Platforms and Tesla - accounted for more than half of the index's gains.

The index has delivered annual returns of approximately 25% in the last two years. If this growth rate holds up, investors could potentially double their dollars every three years by investing in one of the S&P 500 ETFs. According to Trendlyne, returns were even higher for growth or momentum ETFs, some of which delivered over 35% returns in 2024.

But now, analysts are waiting for the other shoe to drop. Valuations have ballooned, especially for the Magnificent 7, while revenues in promising new areas have failed to materialize. Even superstar investorWarren Buffet has increased cash reserves significantly to over $300 billion, around 28% of total assets.

Volatility worries are also turning up in analyst reports. Donald Trump, the incoming US President, with his all-caps social media pronouncements ("TIKTOK IS LESS OF A DANGER TO THE USA THAN META (FACEBOOK!), WHICH IS A TRUE ENEMY OF THE PEOPLE"), and his impulsiveness, makes market watchers nervous. The S&P 500 is trading at a discount of around 3% from its December high, ahead of Trump's swearing in on January 20.

Commenting on long-term treasury yields nearing 5% levels, Torsten Slok, Chief Economist at Apollo Global, said, “80% of the increase in long rates since September has been driven by worries about fiscal policy (under Trump).” The Trump administration is likely to give analysts at least a few sleepless nights this year.

AI was in the driver's seat in 2024. What happens now?

More than 40% of companies in the index mentioned “AI” during earnings calls as they race to stay competitive in this once in a generation technology shift. NVIDIA, a leading player in AI chips, saw its valuation nearly triple in one year.

According to a Citigroup report on AI, more than half (54%) of the jobs in the finance sector have a high potential for automation. Other sectors with significant automation potential include insurance (48%), energy (43%), capital markets (40%), and travel (38%).

The Mag 7 drove gains for the S&P 500 in 2024. But AI for all its hype, has yet to deliver the money. The 2025 outlook for big tech is less rosy, with rising expenses and little to no return from AI-based services so far. Trendlyne’s Forecaster predicts a modest 7.3% median upside for the Mag 7 in 2025, a notable decline from the median return of over 50% in 2024.

Mag 7’s share of S&P 500 market cap has tripled over the past decade

The winners: semiconductors, healthcare, pharma led industry performance in 2024

Over the past year, semiconductors, electronic equipment, healthcare services, specialty pharma and airlines were the top performers, soaring 70% and more. Semiconductor and electronic equipment companies were fueled by the growing demand for AI applications, 5G networks, and the Internet of Things (IoT), while airline companies benefitted from more travel. Tourists were getting sprayed with water in Barcelona, and the normally mild Japanese were complaining about local transport services being overwhelmed. But tourist traffic kept growing.

Healthcare services and specialty pharma also witnessed strong growth, rising by 73.5% and 70.3%, respectively, over the past year. 

Semiconductors lead with a 93.8% rise, while oil, steel, and discount retailers lag

On the other hand, discount retailers, alcoholic beverages, and steel were among the laggards. Companies like Dollar Tree and Five Below were impacted due to slower consumer spending.

In 2021, the average American over 21 consumed alcohol in an amount equivalent to over 600 standard drinks. But recent state health warnings, and shifts in behavior towards non-alcoholic drinks among younger Americans, is hurting the alcohol industry. Meanwhile, cable/ satellite and steel industries declined by over 13% in the past year.

Analysts predict modest gains for the S&P 500 in 2025

For 2025, the median forecast for S&P hints at a modest outlook, with the index projected to reach 6,600, an 8.2% return. Wells Fargo's high estimate points to a 14% return, while UBS' conservative estimate suggests only a 5% gain. Interestingly, no forecasts predict a negative return for the year. 

Wells Fargo predicts street high S&P 500 target of 7,007 for 2025

Goldman Sachs highlights the correlation between corporate revenue growth and nominal GDP growth, saying, “Corporate revenue growth (at the index level) typically moves in line with nominal GDP growth. Our estimate of 5% sales growth for the S&P 500 is consistent with our forecasts for 2.5% real GDP growth and for inflation to cool to 2.4% by the end of next year.”

The incoming Trump presidency could shake up markets with tax cuts, tariffs, and deregulation

From Trump’s inauguration in 2017 to his final day in office, the S&P 500 rose at a CAGR of 13.8%. This was a significant rise even with the pandemic selloff in March 2020, which saw the market’s worst period in decades. Trump’s 2024 re-election can mean more action on tariffs, deportations, deregulation, and tax cuts.

Trump’s 2017 tax cuts increased deficits, with the US trade deficit rising by 41.2% between 2016-2020, the highest since 2008. If Trump's new tax plans are implemented as expected, US debt might rise to 141% of GDP by 2034, compared to 134% without any policy changes. If all his tax promises are fulfilled, debt could increase even more, reaching 150% of GDP.

The stricter immigration rules Trump wants may reduce the labor supply, affecting sectors like hospitality, agriculture, and technology, which rely heavily on foreign labor. Companies reliant on Chinese imports could see a rise in raw material costs with tariffs, which may squeeze profit margins, particularly in the technology, consumer electronics, and manufacturing sectors. But relaxed antitrust regulations may boost mergers, especially in tech, healthcare, and energy.

Trump is promising big changes. The road from promises to policies however, is long and arduous, especially with the thin majorities the Republicans have in the House and Senate.

logo
The Baseline
17 Jan 2025
Five Interesting Stocks Today - January 17, 2025
By Trendlyne Analysis

1. L&T Technology Services:

This IT consulting & software firm surged over 8% on Thursday following the announcement of its Q3 results. Eight large deals secured over the past quarter drove this increase. CEO Amit Chadha further fueled the rise by assuring investors that the company is on track to achieve its $2 billion revenue target in the medium term with an EBIT margin of 17-18%.

In Q3, the company reported sequential revenue growth of 1.8%, reaching Rs 2,687 crore, while net profit rose by 0.9% to Rs 322 crore. The profit remained flat QoQ, primarily due to wage hikes and one-time costs associated with the Intelliswift acquisition. Although revenue for the quarter aligned with Forecaster estimates, net profit fell short of estimates by 3.1%. 

LTTS operates across three segments: mobility, sustainability, and technology, with each segment contributing roughly equal revenue. Over the past quarter, the firm won two large deals in mobility. It also secured two new deals in the sustainability segment. Additionally, it announced three deal wins in the technology segment. 

Regarding future deals, CEO Amit Chadha said, “LTTS is seeing a good number of large deals in the pipeline across all three segments.” He also emphasised that FY26 will outpace FY25 in terms of deal wins. Chadha is confident in the firm's outlook of achieving 10% revenue growth in FY25, including the contribution of Intelliswift.

Post Q3 results, Sharekhan maintains a ‘Buy’ rating on LTTS. Analysts at Sharekhan expect the firm to witness a higher growth trajectory supported by the Intelliswift acquisition, which opens avenues to service three new sectors: retail, fintech, and healthcare. With a target price of Rs 6,500, the stock has a potential upside of over 20%.

2. Biocon:

This biotechnology company has risen by over 6% in the past week and touched a 52-week high of Rs 397.8 today. On January 12th, the company's Malaysian subsidiary received USFDA approval for its insulin units. Motilal Oswal notes that after this approval, all the company’s key biosimilar sites are USFDA-compliant, improving its prospects in the US market. The approval of the Malaysian site opens up commercial opportunities for its ‘B-Aspart’ (synthetic insulin) drug, whose US market size is estimated at $800 million (approximately Rs 6,640 crore).

The company had reported a net loss and a flat revenue in Q2FY25 due to delayed approvals for the US market and increased financial leverage. However, Trendlyne Forecaster estimates the company’s revenue to rise by 9.2% in Q3FY25. HSBC Securities expects an operational turnaround for Biocon driven by multiple catalysts, including its strong pipeline of biosimilars and a recovery in the generics sector, fueled by high-value launches such as generic GLP-1 products (used for weight loss and diabetes treatment). The company also appears on a screener of stocks with strong momentum.

Kedar Upadhye, Chief Financial Officer of the company, discussed the high debt situation in the biologics space, “Net debt in Biologics, which was around Rs 10,800 crore, has now decreased by about Rs 410 crore as of September 30th. Capex for the year is expected to be between Rs 750-830 crore, with half allocated to maintenance and the other half to expanding insulin capacity in Malaysia, driven by strong demand and pricing in global markets.” 

Motilal Oswal has upgraded Biocon to a ‘Buy’ rating with a target price of Rs 430. The brokerage forecasts a 21% EBITDA CAGR over FY25-27. Given the focus on compliance and the potential business from upcoming products, it has raised the EV/EBITDA multiple for the biologics business to 22x on a 12-month forward basis. Additionally, it notes that timely approval of 'B-Aspart' could offer further upside to biologics sales over FY25-27. It expects Biocon’s potential sales from this product to reach at least $80-100 million (approximately Rs 664 crore to Rs 830 crore).

3. PCBL Chemical:

This petro-products maker has declined by 9.8% over the past week after announcing its Q3FY25 results on January 10. During the quarter, its net profit fell 37.1% YoY to Rs 93.1 crore due to higher material and finance costs, employee benefits and other expenses. Revenue was up 21.3% YoY at Rs 2,010 crore. The company’s net profit missed Forecaster estimates by 7.2%, while revenue missed estimates by 2.3%.

During the December quarter, revenue growth was driven by increased volumes (up 5% YoY at 143,500 MT) and the inclusion of the Aquapharm business. PCBL Chemical acquired Pune-based specialty water chemicals maker Aquapharm Chemicals in January 2024, marking its foray into the global specialty segments including water treatment chemicals and oil & gas chemicals.

PCBL’s carbon black segment (which contributes to over 81% of the total revenue) grew by 2% YoY during the quarter. Sales growth was slower compared to Q2FY25 (up 21.5% YoY) due to a drop in realizations amid crude oil price fluctuations. Commenting on this, Raj Gupta, CFO of the company said, “Volatility in crude prices has affected our realizations, as our main raw material is derived from crude. Additionally, a change in product mix during the quarter also impacted our performance”. Meanwhile, the power segment declined by 1.5% YoY during the quarter. 

During Q3FY25, the company commissioned the second and final phase of its 20,000 MTPA (metric tons per annum) specialty chemical capacity at the Mundra Plant in Gujarat, increasing its total installed capacity to 790,000 MTPA. 

Following PCBL’s results announcement, Nuvama lowered its rating to ‘Hold’ with a target price of Rs 397. The brokerage believes PCBL’s long-term growth prospects look promising with business diversification, but high debt levels and a potential turnaround in Aquapharm remain key factors to monitor.

4. Anand Rathi Wealth:

This capital markets company fell 3.5% on January 13 following the announcement of its Q3FY25 results. Anand Rathi Wealth's (ARW) revenue increased by 29.9% YoY to Rs 237 crore, but it missed Trendlyne Forecaster estimates by 2.6%. Net profit grew 33.3% YoY to Rs 77.3 crore for the quarter. The company also declared a 1-for-1 bonus share issue, offering one bonus share for every equity share held.

The firm’s assets under management (AUM) grew by 38.8% to Rs 76,402 crore. Equity mutual funds (MF) made up 55% of the total AUM, up from 52% in Q3FY24, while debt MF accounted for 5%, down from 9%. The company had initially set an AUM guidance of Rs 72,000 crore for the year, but having exceeded this target, management has revised the guidance to Rs 80,000 crore.

The company’s MF AUM stands at Rs 45,875 crore, which accounts for 1.37% of the total market, valued at around Rs 30 lakh crore. Deputy CEO, Feroz Aziz mentioned that the company aims to increase its market share to 4%. He outlined that achieving this target relies on two key factors: attracting funds faster than the industry average and ensuring the company’s portfolio outperforms the average equity MF. He highlighted that ARW’s portfolio, consisting of 14 schemes, has outperformed the Nifty by around 7.5-8% this financial year, which should help achieve the target.

The company added 1,785 new client families over the past year, increasing its total client base to 11,426. While ARW's stock price has declined by 7.3% in the last month, it outperformed its industry by 4%.

Post results, Motilal Oswal maintains its 'Neutral' rating on the stock. The brokerage projects a revenue and AUM CAGR of 26%, and 28% for PAT over FY25-27, supported by the company’s strong cash flow of Rs 890 crore, a return on equity (RoE) above 40%, and a healthy balance sheet. With a target price of Rs 4,200, the stock has a potential upside of 5.7%.

5. Angel One:

This brokerage company has fallen 6.5% over the past week. The stock faced selling pressure after the company reported its lowest quarterly profit increase (8.1% YoY) in Q3FY25 since its 2020 listing, due to stricter regulations in the derivatives market. 

SEBI introduced new rules in October 2024 that limit retail investor participation in Futures & Options (F&O). These changes included raising the minimum contract size, cutting weekly expiries, requiring upfront premium payments, and stopping popular contracts. Angel One reported a 13% QoQ drop in F&O brokerage to Rs 662.7 crore, with the segment contributing 52.5% to the company’s total revenue in Q3FY25.

Angel One’s revenue increased by 19.1% YoY to Rs 1,263.8 crore. The company also announced a dividend of Rs 11 per equity share, totaling Rs 99.3 crore. This represents 35.3% of the consolidated net profit for Q3FY25.

Dinesh Thakkar, Managing Director of Angel One, stated, “Although a few regulations introduced this quarter caused a temporary industry-wide impact, our aggressive client acquisition strategy, along with the normalization of client activity, will fuel renewed growth momentum in the coming quarters.”

Motilal Oswal lowered its target price while maintaining a ‘Buy’ rating. The revised target price of Rs 3,200 suggests a potential upside of 28.2% from the current market price. The brokerage says that Angel One has managed to maintain its profitability by changing its pricing to cover the impact of fee transparency regulations.

Trendlyne's analysts identify stocks that are seeing interesting price movements, analyst calls, or new developments. These are not buy recommendations.

Trendlyne Marketwatch
Trendlyne Marketwatch
17 Jan 2025
Market closes lower, AstraZeneca gets CDSCO approval to import and sell Soliris drug in India
By Trendlyne Analysis

Nifty 50 closed at 23,203.20 (-108.6, -0.5%) , BSE Sensex closed at 76,619.33 (-423.5, -0.6%) while the broader Nifty 500 closed at 21,680.25 (-34.3, -0.2%). Market breadth is neutral. Of the 2,394 stocks traded today, 1,205 were gainers and 1,152 were losers.

Indian indices closed lower, with the benchmark Nifty 50 index closing at 23,202 points. The Indian volatility index, Nifty VIX, rose 1.8% and closed at 15.8 points. Infosys' net profit grew 4.6% QoQ to Rs 6,806 crore in Q3FY25, while revenue increased 1.9% QoQ to Rs 41,764 crore.

Nifty Smallcap 100 and Nifty Midcap 100 closed in the green. S&P BSE Energy and Nifty Oil & Gas closed higher. According to Trendlyne’s sector dashboard, Fertilizers emerged as the best-performing sector of the day, with a rise of 2.3%.

European indices are trading higher. Major Asian indices closed mixed. US index futures are trading in the green, indicating a positive start to the trading session. Truist Financial Corp, Schlumberger NV, Fastenal, and Wipro are set to report their earnings later today.

  • Money flow index (MFI) indicates that stocks like Minda Corp, PTC Industries, and Equitas Small Finance Bank are in the overbought zone.

  • Steel Strips Wheels falls sharply as its revenue declines by 3.2% YoY to Rs 1,074.7 crore in Q3FY25, missing Forecaster estimates by 2.9%. Net profit drops by 19.7% YoY to Rs 477.1 crore during the quarter. It appears in a screener of stocks near their 52-week low.

  • Geojit BNP Paribas maintains its 'Buy' call on Avenue Supermarts with a target price of Rs 4,107 per share. This indicates a potential upside of 13.4%. The brokerage believes the company's strong balance sheet and operational efficiency will support ongoing store expansions, helping revenue growth. It expects the firm's revenue to grow at a CAGR of 17.6% over FY25-27.

  • AstraZeneca Pharma India gets approval from the Central Drugs Standard Control Organisation (CDSCO) to import and sell Eculizumab (Soliris) in India. The drug treats two rare blood disorders that can lead to blood clots, organ damage, kidney failure, and severe complications.

  • OPEC's share of India's crude oil imports increased to 51.5% in 2024, marking its first rise in nine years, while Russia's share remained stable at 36%. India's total oil imports rose by 4.3% YoY to 4.8 million barrels per day. However, Russia's share is expected to decline in 2025 following new US sanctions on Russian producers and tankers.

  • Ganesh Housing Corp's Q3FY25 net profit grows 60% YoY to Rs 160.8 crore, helped by inventory destocking, tax returns of Rs 54.8 crore and lower employee benefits, finance, and depreciation & amortisation costs. Revenue increases 44% YoY to Rs 264.1 crore during the quarter. It features in a screener of stocks with improving return on capital employed (RoCE) over the past two years.

  • Indian Renewable Energy Development Agency (IREDA) rises as it signs an agreement with six entities to execute and operate the 900 MW Upper Karnali hydro-electric power project in Nepal.

  • Aether Industries rises sharply as its net profit surges by 149% YoY to Rs 43.4 crore in Q3FY25, led by inventory destocking. Revenue grows 40% YoY to Rs 233.3 crore, driven by improvements in the large-scale manufacturing, contract manufacturing, and contract research & manufacturing services (CRAMS) segments. It features in a screener of stocks with improving cash flow for the past two years.

  • Umang Nahata, CEO of Mastek, highlights the company's target to boost margins by 200 bps to 19% over the next two years. He anticipates an improvement in performance in Q4, as wage hikes in Q3 impacted margins by 160 bps. Nahata adds that the company is exploring investments in Europe through tuck-in acquisitions.

  • C.E. Info Systems (MapMyIndia) partners with Qualcomm Technologies to develop advanced automotive solutions under the ‘Make in India’ initiative. MapMyIndia will use Qualcomm's Snapdragon auto connectivity platform to create cost-effective telematics, enhancing connectivity and safety for the mass market.

  • Metro Brands is falling as its Q3FY25 net profit declines 3.3% YoY to Rs 94.6 crore, caused by higher employee benefits, finance, and depreciation & amortisation expenses. However, revenue grows 11.5% YoY to Rs 726.3 crore, helped by increased sales due to the festive and wedding season. It appears in a screener of stocks where promoters have reduced their shareholding by more than 2% QoQ.

  • Havells India rises as its revenue grows by 10.8% YoY to Rs 4,889 crore in Q3FY25, driven by an increase in switchgear, cables, lighting & fixtures, electrical consumer durables, and Lloyd consumer segments. However, net profit falls by 3.3% YoY to Rs 278.3 crore due to higher raw material, employee benefits, and depreciation & amortisation expenses. It appears in a screener of stocks where mutual funds increased their holding in the past quarter.

  • The World Bank, in its Global Economic Prospects report, states that India will continue to be the world's fastest-growing economy over the next two years despite a slowdown. It maintains its previous growth forecast of 6.7% for FY26. The report also highlights that GDP growth in the broader South Asian region will likely reach 6.2% in 2025 and 2026, primarily driven by India's strong performance.

  • AIA Engineering's board of directors approves setting up two Hi-Chrome Grinding Media manufacturing facilities in China and Ghana with a capacity of 50,000 million tonnes per annum (MTPA) each and a capex of $50 million (~ Rs 432.9 crore) through its subsidiary, Vega Industries (Middle East). The company is also considering setting up similar facilities in Indonesia and other locations.

  • Capital Infra Trust’s shares debut on the bourses at a 1% discount to the issue price of Rs 100. The Rs 1,578 crore IPO received bids for 2.8 times the total shares on offer.

  • Hatsun Agro Products falls sharply as its Q3FY25 net profit declines 28.7% YoY to Rs 40.9 crore due to higher employee benefits, finance, and depreciation & amortisation expenses. However, revenue grows 6.4% YoY to Rs 2,012 crore during the quarter. It shows up in a screener of stocks near their 52-week lows.

  • UBS upgrades APL Apollo Tubes to a 'Buy' rating with a higher target price of Rs 1,900. The brokerage believes the company could positively surprise the market with sustained demand momentum. It also notes that hot rolled coils (HRC) prices, which are typically inversely correlated with APL volumes, have dropped around 14% YoY in the last 6 months, which is positive for the company’s volume growth.

  • HFCL secures an advance work order worth Rs 2,501.3 crore from Bharat Sanchar Nigam (BSNL) for BharatNet Phase III in Punjab. The project involves design, construction, and maintenance and has a three-year construction timeline.

  • Bajaj Healthcare surges more than 10% as it receives exclusive rights from Threotech to manufacture, distribute and sell the finished formulation of Magnesium L Threonate. The drug is used to treat depression, Alzheimer's disease, and age-related memory loss and has a market size of $438 million.

  • Bharat Petroleum Corp rises as it finalises a Rs 31,802 crore loan from an SBI-led consortium to fund a petrochemical complex and expand refinery capacity at Bina, Madhya Pradesh. The consortium includes the State Bank of India, Punjab National Bank, Union Bank of India, Canara Bank, Bank of India, and Export-Import Bank of India.

  • Citi initiates a 'Buy' rating on Aadhar Housing Finance with a target price of Rs 565. The brokerage expects steady growth in assets under management (AUM) at a 16% CAGR over the next 4-6 years and highlights its diversified distribution. Meanwhile, it points out the risks of promoter dilution and the increasing share of informal self-employed borrowers.

  • LTIMindtree is falling sharply as its net profit declines 13.2% QoQ to Rs 1,085.4 crore in Q3FY25, helped by lower finance costs. Revenue grows 1.5% QoQ to Rs 9,873.4 crore, led by improvements in the banking, financial services, & insurance (BFSI), manufacturing & resources, consumer business, and healthcare, life sciences & public services segments. It shows up in a screener of stocks where insiders sold their stakes.

  • Reliance Industries is rising as its revenue grows by 7% YoY to Rs 2.4 lakh crore in Q3FY25, driven by improvements in the oil to chemicals (O2C), retail and digital services segments. Net profit rises 7.4% YoY to Rs 18,540 crore, surpassing the Forecaster estimates by 3.1%. It features in a screener of stocks outperforming their industry price change in the quarter.

  • Axis Bank is falling sharply as its Q3FY25 net profit misses Forecaster estimates by 2.6%, despite growing 3.8% YoY to Rs 6,303.8 crore. Revenue increases 10.2% YoY to Rs 36,926.1 crore, helped by improvements in the treasury, corporate, and retail banking segments. The bank's asset quality improves as its gross NPA declines by 12 bps YoY.

  • Infosys' net profit grows 4.6% QoQ to Rs 6,806 crore in Q3FY25. Revenue increases 1.9% QoQ to Rs 41,764 crore, attributed to improvements in the financial services, retail, communication, energy, utilities, resources & services, manufacturing, hi-tech, and life sciences segments. It features in a screener of stocks with increasing net profit and profit margin (QoQ).

  • Nifty 50 was trading at 23,184.10 (-127.7, -0.6%), BSE Sensex was trading at 77,069.19 (26.4, 0.0%) while the broader Nifty 500 was trading at 21,609.95 (-104.6, -0.5%).

  • Market breadth is sharply down. Of the 1,902 stocks traded today, 616 were on the uptrend, and 1,232 went down.

Riding High:

Largecap and midcap gainers today include IDBI Bank Ltd. (84.01, 5.5%), Hindustan Aeronautics Ltd. (4,116.60, 5.1%) and Macrotech Developers Ltd. (1,176.95, 4.3%).

Downers:

Largecap and midcap losers today include Infosys Ltd. (1,815.45, -5.9%), PB Fintech Ltd. (1,724.40, -4.9%) and Axis Bank Ltd. (991.05, -4.5%).

Crowd Puller Stocks

14 stocks in BSE 500 are trading on high volumes today.

Top high volume gainers on BSE included BLS International Services Ltd. (501.85, 11.2%), NBCC (India) Ltd. (95.31, 8.5%) and Gujarat State Fertilizer & Chemicals Ltd. (208.86, 7.4%).

Top high volume losers on BSE were Axis Bank Ltd. (991.05, -4.5%), Aether Industries Ltd. (821.65, -3.8%) and Sonata Software Ltd. (571, -2.5%).

Gujarat State Petronet Ltd. (364, 3.7%) was trading at 53.8 times of weekly average. Go Digit General Insurance Ltd. (290.70, -0.4%) and Bharat Dynamics Ltd. (1,276.25, 6.2%) were trading with volumes 14.1 and 4.5 times weekly average respectively on BSE at the time of posting this article.

BSE 500: highs, lows and moving averages

1 stock made 52 week highs, while 4 stocks were underachievers and hit their 52 week lows.

Stock touching their year highs included - Biocon Ltd. (393.70, 0.1%).

Stocks making new 52 weeks lows included - Axis Bank Ltd. (991.05, -4.5%) and Relaxo Footwears Ltd. (579.75, 0.5%).

17 stocks climbed above their 200 day SMA including Bharat Dynamics Ltd. (1,276.25, 6.2%) and Manappuram Finance Ltd. (193.75, 5.8%). 11 stocks slipped below their 200 SMA including Kotak Mahindra Bank Ltd. (1,758.60, -2.6%) and Tata Consultancy Services Ltd. (4,124.30, -2.0%).

logo
The Baseline
16 Jan 2025
By Aditi Priya

2024 was an eventful one for investors. The Nifty 50 and Sensex delivered gains of 8.8% and 8.2%, respectively, while broader markets outperformed. The Nifty Midcap 100 and Smallcap 100 indices rose by more than 20%.

However, the final quarter gave investors whiplash, with the Nifty 50 declining nearly 12% from its September peak. Disappointing quarter results and high foreign fund outflows in October and November drove markets down. Still, the year ended with positive returns, marking the ninth consecutive year of gains for the Indian equity market. 

Of the 130 industries tracked on Trendlyne’s industry dashboard, 87 outperformed the Nifty 50 index in 2024. In this Chart of the Week, we highlight the top-performing industries and their major contributors over the past year.

Manufacturing and industrial sectors see steady growth in 2024

India's manufacturing and industrial sectors were the stars of 2024. Industries like heavy electrical equipment, consumer electronics, industrial machinery, and other electrical equipment rose over 70% in the past year.

The manufacturing PMI consistently stayed above the 50-mark, indicating sustained expansion in these industries. Increasing foreign investments, an expanding domestic market, and government initiatives like ‘Make in India’ and ‘Atmanirbhar Bharat’ drove this growth. 

Among standout companies in these industries, Siemens (heavy electrical equipment) rose 39.8% over the past year. It also reported strong financial performance over the past 12 months. Its trailing twelve month (TTM) revenue and net profit increased by 38.5% and 13.7%. The surge in demand for electrification and data centers, driven by advancements in artificial intelligence (AI), led to high growth.

Dixon Technologies (consumer electronics) capitalized on the PLI scheme to expand its mobile phone manufacturing segment, boosting its revenue share in this category from 12% in FY20 to 62% in FY24.

Jyoti CNC, a metal cutting CNC machines manufacturer, launched its IPO in January 2024. The IPO received a strong response from investors, with an overall subscription of 40.5 times. Since its listing, the company has delivered returns of 260.9%. The rally is fueled by the company's strong financial performance, growing order book, and rising global demand for CNC machines, especially in aerospace. Jyoti CNC's total order book reached Rs 4,289.3 crore by the end of Q2FY25.

Similarly, Waaree Energies, a leading player in the other electrical equipment industry, launched its IPO in October 2024. As India's largest solar photovoltaic (PV) module manufacturer, the IPO saw high demand and was oversubscribed 76.3 times, including 11.3 times by retail investors. Since its debut, the company has delivered impressive returns of over 73.6%. As of September 30, 2024, its order book stood at 20 GW.

Financial services surged due to strong foreign inflows and increased retail participation

The banking and finance sector, including industries like exchanges, capital markets, and other financial services, saw notable performance improvements over the past year. 

In 2024, strong foreign institutional inflows (in seven out of 12 months) and increased retail participation drove India's stock markets to record highs. New demat accounts rose 33% in 2024 compared to 2023, bringing the total to 18.5 crore.

Top performers from exchanges, capital markets, and other financial services industries include Bombay Stock Exchange (BSE), Multi Commodity Exchange, Motilal Oswal, KFIN Technologies and Central Depository Services (CDSL)

BSE shares surged 158.6% in 2024, fueled by its expansion of derivatives offerings and the anticipation of the National Stock Exchange’s (NSE) IPO. SEBI's regulatory changes favoring BSE's weekly Sensex options and strong financial performance also contributed to this growth. BSE’s TTM revenue and net profit grew by 17.1% and 119.3%, respectively.

CDSL maintained its dominant position with a 73% market share in demat accounts (September 2024). NSE's potential IPO boosted positive sentiment toward market infrastructure firms like CDSL, anticipating benefits from increased market activity.

Credit rating agency CRISIL's share price rallied by over 41% in 2024 after it acquired a 4% stake in Online PSB Loans (OPL) for Rs 33.3 crore, enhancing its presence in the digital credit infrastructure ecosystem. The company also reported strong financial results over the past year, with a 10.4% TTM net profit increase, and maintained consistent dividend payouts.

The services sector thrived due to rising demand and increased digital adoption

The services sector, including industries like hotels, internet software & services, and internet & catalogue retail industries, showed strong performance in 2024. The PMI for the services sector surged to a four-month high of 60.8 in December 2024, up from 58.4 in November, reflecting a strong rise in demand. 

The hospitality industry benefited from a rebound in travel and tourism, while internet-based services experienced growth due to increased digital adoption and e-commerce activities. Top performers include Indian Hotel Company, Chalet Hotels, Zomato, Swiggy, Brainbees Solutions and PB Fintech.

Indian Hotels Company's (IHCL) share price surged 75.8% in 2024. The company unveiled its ‘Accelerate 2030’ strategy in November 2024, aiming to double its hotel count and revenue by FY30. This plan includes expanding its portfolio to over 700 hotels, up from 350 in FY24, and increasing consolidated revenue to Rs 15,000 crore. 

Zomato's share price rose over 74% over the past year as the company reported a 249.4% increase in net profit TTM. In December 2024, Zomato joined India's BSE Sensex index, becoming the first new-age tech company to do so.

In 2024, Swiggy and Brainbees Solutions (FirstCry) launched their IPOs in the Indian market. Both IPOs received significant investor interest and were oversubscribed. Swiggy expanded its quick commerce services via Instamart, aiming for 10-minute grocery deliveries. The company increased warehouse size and cut delivery times, with quick commerce now making up 40% of its food delivery volume since 2020.

Trendlyne Marketwatch
Trendlyne Marketwatch
16 Jan 2025
Market closes higher, HDFC Life's net profit grows 14.6% YoY to Rs 421.3 crore in Q3
By Trendlyne Analysis

Nifty 50 closed at 23,311.80 (98.6, 0.4%), BSE Sensex closed at 77,042.82 (318.7, 0.4%) while the broader Nifty 500 closed at 21,714.55 (163.4, 0.8%). Market breadth is overwhelmingly positive. Of the 2,393 stocks traded today, 1,749 were in the positive territory and 609 were negative.

Indian indices closed higher, with the benchmark Nifty 50 index closing at 23,311.8 points. The Indian volatility index, Nifty VIX, rose 1.3% and closed at 15.5 points. Bharat Dynamics closed sharply higher as it bagged an order worth Rs 2,960 crore from the Ministry of Defence to supply medium-range surface-to-air missiles for the Indian Navy.

Nifty Smallcap 100 and Nifty Midcap 100 closed in the green. Nifty Metal and Nifty PSU Bank closed higher. According to Trendlyne’s sector dashboard, Transportation emerged as the best-performing sector of the day, with a rise of 2.3%.

European indices are trading higher, except for Spain’s IBEX 35 and Germany’s DAX. Major Asian indices closed mixed. US index futures are trading mixed, indicating a cautious start to the trading session. Bank of America, Morgan Stanley, U.S. Bancorp, and UnitedHealth Group are set to report their earnings later today.

  • L&T Technology Services sees a long buildup in its January 30 futures series, with open interest increasing by 23.8% and a put-call ratio of 0.7.

  • Mastek's revenue rises 10.9% YoY to Rs 869.5 crore in Q3FY25, driven by improvements in the UK & Europe and North Americas operations. Net profit grows 25.8% YoY to Rs 94.7 crore during the quarter. It features in a screener of stocks with increasing net profit and profit margin (QoQ).

  • Alok Industries is falling as its net loss expands by 18.7% YoY to Rs 273 crore in Q3FY25 due to higher finance and power & fuel costs. Revenue plunges 30.5% YoY to Rs 870.6 crore during the quarter. It shows up in a screener of stocks with low Piotroski scores.

  • HDFC Life Insurance surges as its net profit grows 14.6% YoY to Rs 421.3 crore in Q3FY25. However, revenue declines 36.5% YoY to Rs 16,979.3 crore, impacted by lower earnings from funds managed under the shareholders’ account. It shows up in a screener of stocks where mutual funds increased their holding in the past quarter.

  • Bernstein notes that 2024 was a strong year for internet companies, with the sector delivering over 50% returns. The brokerage expects this trend to continue in 2025. It has an 'Outperform' rating on Zomato, Swiggy, and Info Edge, with target prices of Rs 315, Rs 635, and Rs 8,630, respectively.

  • Sterling & Wilson Renewable Energy surges as it posts a net profit of Rs 14.8 crore in Q3FY25 compared to a net loss of Rs 63.8 crore in Q3FY24, helped by lower employee benefits and finance costs. Revenue grows 3x YoY to Rs 1,842.7 crore, driven by improvements in the engineering, procurement & construction (EPC) and operation & maintenance service segments. It features in a screener of stocks with decreasing promoter pledges.

  • DB Corp is falling as its net profit declines 4.7% YoY to Rs 118.2 crore in Q3FY25. Revenue falls 1.4% YoY to Rs 655.6 crore, impacted by the printing, publishing and allied businesses. It shows up in a screener of stocks with weakening technicals and share price decline.

  • Gland Pharma receives an establishment inspection report (EIR) from the US FDA following a good manufacturing practices (GMP) inspection at its Dundigal facility in Hyderabad in July 2024, marking the closure of the inspection.

  • Ashwani Kumar, Managing Director & CEO of UCO Bank, states the bank has received approval from the Government of India to raise Rs 2,000 crore through a QIP, which will result in a 3% reduction in the government’s stake. He adds that the bank aims to achieve a 75% credit-deposit (CD) ratio, a target in line with their previous guidance.

  • Indian Railway Finance Corp rises sharply after signing a Rs 250 crore lease agreement with NTPC to finance eight bogie open bottom rapid (BOBR) rakes. This marks the first phase of funding for 20 rakes under the General Purpose Wagon Investment Scheme (GPWIS).

  • Bharat Dynamics rises sharply as it bags an order worth Rs 2,960 crore from the Ministry of Defence (MoD) to supply medium-range surface-to-air missiles (MRSAM) for the Indian Navy.

  • EMS is rising sharply as it bags an order worth Rs 105.1 crore from Deltabulk Shipping India to develop, operate, and maintain the Multimodal Logistics Park (MMLP) in Nagpur on a design, build, finance, operate, and transfer (DBFOT) basis.

  • Rubicon Research, a leading player in the pharma sector, plans to raise Rs 500 crore through an initial public offering (IPO) to support inorganic growth, strategic initiatives, and loan repayment. The company recently acquired Alkem Laboratories' Pithampur (Madhya Pradesh) facility for Rs 149 crore through a slump sale.

  • Nazara Technologies rises sharply as its board of directors schedules a meeting on January 20 to consider and approve raising funds through a preferential issue of shares.

  • Punjab & Sind Bank is surging as its net profit grows 146.7% YoY to Rs 282 crore in Q3FY25, helped by lower employee benefits expenses. Revenue increases by 14.6% YoY to Rs 3,269.4 crore, led by improvements in the treasury and corporate banking segments. The bank's asset quality improves as its gross and net NPAs decline by 187 bps YoY and 55 bps YoY, respectively.

  • Gensol Engineering rises sharply as it partners with Refex Green Mobility (Refex eVeelz) to transfer 2,997 electric four-wheelers valued at Rs 315 crore. Refex eVeelz will integrate these into fleet operations and lease them to Blu-Smart Mobility.

  • According to a poll of analysts, the weakening Indian rupee could drive up inflation due to more expensive imports. They anticipate the Reserve Bank of India will make policy adjustments at its February meeting, though many now expect the rate cuts to be delayed until April-June. Since Trump's victory, the rupee has depreciated by about 3% against the rising US dollar in just over two months, marking a sharp shift from nearly two years of relative stability and low volatility.

  • GAIL (India) is rising as it enters a settlement agreement with SEFE Marketing & Trading Singapore worth $285 million (~ Rs 2464.4 crore). As per the agreement, the companies will withdraw the arbitration proceedings before the London Court of Arbitration.

  • Azad Engineering is surging as it bags an order worth $112 million (~ Rs 960 crore) from GE Vernova International, USA, to supply airfoils for advanced gas turbine engines.

  • Ceat falls sharply as its Q3FY25 net profit drops 46.5% YoY to Rs 97.1 crore due to higher raw material costs and other expenses. However, revenue increases 11.4% YoY to Rs 3,299.9 crore, surpassing the Forecaster estimates by 1%. It appears in a screener of stocks with improving book value over the past two years.

  • UBS upgrades Indus Towers to a 'Buy' rating with a target price of Rs 425. The brokerage notes the company is steadily adding towers to support Airtel's rural expansion. It adds that Vodafone Idea is paying Rs 800-1000 crore in dues per quarter and expects potential upside as VI increases tower uptake, improving the tenancy ratio.

  • Oracle Financial Services Software falls sharply as its Q3FY25 net profit declines 6.3% QoQ to Rs 541.3 crore due to higher employee benefits, travel, and professional expenses. However, revenue grows 0.4% QoQ to Rs 1,784.9 crore, helped by an improvement in the product licenses and related activities segment. It shows up in a screener of stocks with growing costs YoY for long-term projects.

  • Rail Vikas Nigam rises sharply as it receives a Rs 3,622.1 crore contract from Bharat Sanchar Nigam (BSNL) for BharatNet's middle-mile network. The project is under a design-build-operate-maintain (DBOM) model and involves a three-year construction phase and 10-year maintenance.

  • AXISCADES Technologies is rising as its board of directors appoints Alfonso Martinez as the Chief Executive Officer (CEO) and Managing Director (MD), effective January 20.

  • L&T Technology Services surges as its net profit grows 0.9% QoQ to Rs 322.4 crore in Q3FY25. Revenue increases 3.1% QoQ to Rs 2,653 crore, driven by improvements in the sustainability and tech segments. It features in a screener of stocks with PEG lower than industry PEG.

  • The market opened on an upbeat note. Nifty 50 was trading at 23,335.75 (122.6, 0.5%), BSE Sensex was trading at 77,158.33 (434.3, 0.6%) while the broader Nifty 500 was trading at 21,756.15 (205.0, 1.0%).

  • Market breadth is surging up. Of the 1,939 stocks traded today, 1,737 were gainers and 178 were losers.

Riding High:

Largecap and midcap gainers today include Rail Vikas Nigam Ltd. (411.15, 10.6%), L&T Technology Services Ltd. (5,244.40, 8.1%) and IDBI Bank Ltd. (79.63, 7.9%).

Downers:

Largecap and midcap losers today include Oracle Financial Services Software Ltd. (10,189.85, -3.4%), Trent Ltd. (6,211.55, -2.8%) and Dr. Reddy's Laboratories Ltd. (1,302.75, -2.6%).

Movers and Shakers

24 stocks in BSE 500 are trading on high volumes today.

Top high volume gainers on BSE included Ircon International Ltd. (220.41, 16%), Jupiter Wagons Ltd. (494.75, 14.2%) and Gujarat Mineral Development Corporation Ltd. (326.90, 11.7%).

Top high volume losers on BSE were Oracle Financial Services Software Ltd. (10,189.85, -3.4%), Ceat Ltd. (3,044, -0.4%) and Endurance Technologies Ltd. (2,070, -0.3%).

L&T Technology Services Ltd. (5,244.40, 8.1%) was trading at 8.3 times of weekly average. HDFC Life Insurance Company Ltd. (641.40, 7.9%) and Punjab & Sind Bank (49.48, 6.9%) were trading with volumes 8.1 and 8.0 times weekly average respectively on BSE at the time of posting this article.

BSE 500: highs, lows and moving averages

1 stock took off, crossing 52 week highs, while 4 stocks tanked below their 52 week lows.

Stock touching their year highs included - Biocon Ltd. (393.15, 2.9%).

Stocks making new 52 weeks lows included - Asian Paints Ltd. (2,215.60, -0.6%) and Relaxo Footwears Ltd. (579.10, 0.4%).

21 stocks climbed above their 200 day SMA including L&T Technology Services Ltd. (5,244.40, 8.1%) and HDFC Life Insurance Company Ltd. (641.40, 7.9%). 8 stocks slipped below their 200 SMA including Oracle Financial Services Software Ltd. (10,189.85, -3.4%) and Kalyan Jewellers India Ltd. (539.20, -2.9%).

logo
The Baseline
15 Jan 2025
A turnaround for Indian pharma in the US | Screener: High momentum pharma stocks
By Tejas MD

The fireworks were soggy for Indian markets in the new year. In the first 15 days of 2025, the Nifty 50 slipped into correction territory, down over 10% from its highs, while the Indian rupee tumbled to a record low, breaching 86 against the US dollar.

According to Bloomberg, the mood will be muted this earnings season as well, as Q3FY25 results could bring a flurry of downgrades.

Pictet Asset Management portfolio manager Prashant Kothari, who oversees about $1 billion in an Indian equity fund, says, “We have had very good economic expansion in India, but there may be clouds on the horizon.” He adds that opportunities in India "are not juicy."

But falling valuations may not be a bad thing, if you know where to look. Warren Buffett loved buying great stocks at discount valuations, and famously said, "Be fearful when others are greedy, and greedy when others are fearful." 

One defensive sector that gets interesting in tough times is pharma. Since 2005, the Nifty 50 has delivered an annual negative return three times, but the Nifty Pharma index has outperformed the benchmark index all three times. 

So which stocks are looking especially strong ahead of Q3FY25 results? Let’s dive in. 

In this week’s Analyticks,

  • Indian pharma companies are adapting - and winning - in a changing US market
  • Screener: Pharma stocks with high momentum and durability scores, with rising operating profit margin in Q2

US market recovery gives Indian pharma a boost

Indian drug makers have seen booms and busts in the past 15 years, due to their heavy reliance on the US generics business. 

The problem with generics? A generic drug contains the same chemical substance as one originally protected by patents. Its main appeal is its lower price.

So competition in the generic drug market is fierce. A single generic option usually causes a 40% fall in the drug's prices, and five to six generic players cause a 90% reduction. As a result, this segment has lower margins, and no product differentiation to bank on. 

Trendlyne’s share price history data shows that Nifty Pharma outperformed the Nifty 50 from 2010 to 2016. This was due to a sharp uptick in US generics sales, which Indian players benefitted from by exporting low-cost generic drugs to the US. 

Nifty Pharma outperforms the Nifty 50 in nine out of past 15 years

But the easy generics money soon ran out, and a slowdown took hold in 2016. US generics became less profitable due to stricter regulations by the US FDA. The regulator also encouraged more generics competition. Nifty Pharma posted negative returns from 2016 to 2019.

Post-Covid, Indian pharma companies pivoted towards specialty and complex generics segments in the US to beat the slowdown in generics sales. Industry leaders like Sun Pharma, Cipla, and Dr Reddy’s embraced this strategy.

This pivot led to Nifty Pharma's sharp rise of 34% in 2023, and 39% in 2024. Relatively smooth USFDA inspections have also contributed to this, allowing Indian drug makers to speed up product launches and enhance profitability in the competitive US market.

However, not all companies enjoyed similar success. Firms like Aurobindo Pharma and Alkem Labs attempted to diversify into specialty injectables and biosimilars but faced challenges. Weak demand and persistent supply chain issues have undermined their efforts, limiting revenue growth.

India vs US: Where is pharma's focus? 

Post-COVID, Indian companies have switched away from the broad generics space in the US, which had high competition, to complex generics (Cipla, Dr Reddy’s), specialty products (Sun Pharma), and peptides. 

Abhay Gandhi, Sun Pharma's CEO (North America Business), said in the Q2FY25 earnings call, “The US specialty business has grown YoY. The underlying prescription trends for the specialty business are strong.” 

This diversification strategy has fueled two growth engines - India and the US. In addition, the number of adverse classification outcomes from US FDA inspections fell in 2024 after a sharp uptick in 2019. 

USFDA’s red flags decrease in 2024

In 2024, 206 USFDA inspections were conducted, of which only 14 (6.6%) resulted in official action (OAI). The OAI percentage has fallen from 11% in 2019. An OAI from the USFDA greatly impacts the profitability and product launch timeline for drugmakers. 

US generics remain an important vertical. Several bestseller drugs are expected to go off-patent in the US, increasing the potential for generic alternatives. This could help offset any lower-than-expected India sales. The Indian pharmaceutical market's growth moderated to 7% in 2024. This was primarily due to a lack of price hikes on the National List of Essential Medicines products and a regulatory ban on 156 fixed-dose combination drugs. 

The US market, on the other hand, has picked up in the last few quarters after a period of underperformance. This was helped by strong sales of the complex generic cancer drug Revlimid (lenalidomide). 

In the generics space, companies must launch new complex generics to find the next blockbuster, which remains a concern. 

Pharma companies expected to post strong numbers in Q3

According to a Q3 result preview report by KR Choksey, pharma companies’ revenue is expected to grow 10.8% YoY, led by strong US business, and domestic growth.

The EBITDA margin is expected to expand 198 bps YoY, led by a favorable product mix and increased focus on complex products. Falling freight and raw material costs are also expected to help margins. The average price of raw materials has fallen around 25% YoY in Q3FY25 to $114/Kg. 

A diverse set of companies, from API manufacturers to branded generics manufacturers, are in the list of players expected to post positive revenue and net profit growth in Q3. 

Divi’s Labs expected to post high revenue and net profit growth

Mankind Pharma depends mainly on Indian market growth (over 90% of revenue share), and its Q3FY25 revenue and net profit are set to increase for the eighth quarter. Its outperformance in market growth with IPM is expected to continue in the chronic segment in Q3. 

Companies like Sun Pharma and Dr Reddy’s get a notable portion of their revenues from the US. While specialty products should drive revenue growth for Sun Pharma, new product launches remain key for Dr Reddy’s. 

Divi’s Labs and Lupin saw a sharp turnaround in the past two years. Divi’s Labs is benefitting from lower raw material prices and high demand in the custom synthesis segment. 

When it comes to Trendlyne’s DVM scores, these pharma companies boast high durability scores. 

Pharma companies have medium momentum scores despite a weak quarter

Despite a weak quarter, these pharma companies’ momentum scores remain in the ‘Medium’ category. Zydus Lifesciences has the highest DVM score. It has good durability, medium valuation, and momentum scores, making it a ‘Mid-range Performer.’ 


Screener: Pharma stocks with high momentum and durability with rising operating profit margin in Q2

Pharma stocks with high momentum scores and rising operating margins

As we enter the results season, we look at stocks from the pharmaceutical industry with good momentum and durability with rising operating profit margin growth in Q2FY25. This screener shows pharmaceutical stocks with high Trendlyne momentum and durability scores with rising operating profit margins in Q2FY25.

Major stocks that feature in the screener are Procter & Gamble Health, Lupin, Granules India, Ipca Laboratories, Mankind Pharma, Orchid Pharma, Innova Captab, and Caplin Point Laboratories

Lupin features in the screener with a good Trendlyne momentum score of 57 and a growth of 5.4 percentage points YoY in operating profit margin in Q2FY25. This pharma stock has a high momentum score, helped by an 18.7% rise in stock price over the past six months. The company’s operating margins improved due to lower freight costs, combined with a better mix of high-margin products, helped by new product launches like Mirabegron in the US and Luforbec in the UK.

Ipca Laboratories also appears in the screener after its operating profit margin grew by 3 percentage points YoY to 18.8% in Q2FY25. Operating margin improved, led by reduced raw material costs and a 25-30% cost reduction in active pharmaceutical ingredient (API) processes at its subsidiary, Unichem Laboratories. It also has a good Trendlyne Momentum score of 59, driven by a 28.7% surge in its stock price over the past six months.

You can find some popular screeners here.

Signing off this week,

The Trendlyne Team

Trendlyne Marketwatch
Trendlyne Marketwatch
15 Jan 2025
Market closes higher, J Kumar Infra bags a Rs 1,073 crore order from NBCC
By Trendlyne Analysis

Nifty 50 closed at 23,213.20 (37.2, 0.2%), BSE Sensex closed at 76,724.08 (224.5, 0.3%) while the broader Nifty 500 closed at 21,551.20 (70.2, 0.3%). Market breadth is balanced. Of the 2,392 stocks traded today, 1,220 were on the uptick, and 1,128 were down.

Indian indices closed in the green, with the benchmark Nifty 50 index closing at 23,213.2 points. The Indian volatility index, Nifty VIX, declined 1.1% and closed at 15.3 points. HDFC AMC’s Q3FY25 net profit grew by 31% YoY to Rs 641.5 crore, while revenue increased by 26.2% YoY, helped by higher assets under management (AUM).

Nifty Smallcap 100 and Nifty Midcap 100 closed in the green, following the benchmark index. S&P BSE Utilities and BSE Power were among the top index gainers today. According to Trendlyne’s Sector dashboard, Retailing emerged as the best-performing sector of the day, with a rise of 2.1%.

Asian indices closed mixed, while European indices are trading in the green, with an exception of Russia’s MOEX & RTSI index. US index futures traded in the green, indicating a positive start to the trading session. Brent crude oil futures are trading in the green. Barclays notes that the S&P 500’s growth in Q4 earnings season depends on technology stocks. It observes that downward revisions for sectors outside tech are 300bps higher than average, signaling bearish sentiment ahead of the reporting season.

  • Relative strength index (RSI) indicates that PTC Industries is in the overbought zone.

  • NESCO rises as it wins a contract from National Highways Logistics Management to develop, operate, and maintain wayside amenities on the Raipur-Visakhapatnam Expressway. The project is expected to cost Rs 200 crore, with an estimated annual revenue of Rs 300 crore from year four of operations.

  • Alembic Pharmaceutical receives final approval from the US FDA for its abbreviated new drug application (ANDA) for Brexpiprazole tablets. The drug is a therapeutic equivalent to Otsuka Pharmaceutical's reference listed drug (RLD), Rexulti tablets, used to treat major depressive disorder (MDD) and schizophrenia. It has an estimated market size of $2 billion for the year ending September 2024.

  • Maharashtra Scooters is rising as its net profit surges 3.3X YoY to Rs 3.3 crore in Q3FY25, helped by lower raw material and employee benefit expenses. However, revenue falls by 9.1% YoY to Rs 5.8 crore due to a reduction in the manufacturing segment. The company appears in a screener of stocks where mutual funds increased their holding in the past quarter.

  • January crude oil futures reach Rs 6,729 on Multi Commodity Exchange (MCX) during the initial hour of trading after a weekly report by the industry body American Petroleum Institute (API) indicated a decline in inventories by 2.6 million barrels in the US for the week ending January 10.

  • Network18 Media & Investments plunges to its 52-week low of Rs 58.2 per share as its Q3FY25 net loss expands to Rs 1,435.5 crore compared to Rs 58.8 crore in Q3FY24 due to higher finance costs. Revenue declines by 25.3% YoY to Rs 1,442.6 crore, led by lower demand during the festive period and reduced advertising volumes. It shows up in a screener of stocks with high interest payments compared to earnings.

  • Premier Energies rises sharply as three subsidiaries secure orders worth Rs 1,460 crore for solar PV cells and modules. These include Rs 1,041 crore to supply modules and Rs 419 crore for cells, starting May 2025.

  • NBCC rises sharply as it secures orders worth Rs 405 crore, including projects for Delhi University's Hindu College, Fakir Mohan University in Odisha, and Maharaja Sriram Chandra University in Mayurbhanj.

  • BofA Securities upgrades Maruti Suzuki India to a 'Buy' rating with a target price of Rs 14,000. The brokerage highlights that the company started its EV journey with the launch of the 'e-Vitara,' and the Toyota alliance has fueled growth, with combined exports now at 20% of volume. It expects a 7.5% volume CAGR and over 10% revenue CAGR for FY25-27.

  • J Kumar Infraprojects is rising as it bags an order worth Rs 1,073.4 crore from NBCC (India) to develop Silicon City Phase-IV Group housing in Sector 76, Noida. The project will be undertaken on an engineering, procurement & construction (EPC) basis, with operations and maintenance for two years.

  • HDFC Asset Management rises sharply as its Q3FY25 net profit grows by 31% YoY to Rs 641.5 crore, beating Forecaster estimates by 7.3%. Revenue increases by 26.2% YoY, helped by higher assets under management (AUM). It features in a screener of stocks with rising net cash flow and cash from operating activities.

  • Quadrant Future Tek surges to its all-time high of Rs 532.8 per share as it appoints Mohit Vohra and Amit Kumar Jain as its Managing Director (MD) and Chief Executive Officer (CEO), respectively.

  • Reports suggest that the Adani Group is in advanced talks with Dubai-based Emaar Properties to acquire a majority stake in its Indian subsidiary, Emaar India, for an estimated Rs 4,000-5,000 crore. The deal will likely involve the acquisition of 70-100% ownership in Emaar India, primarily through Adani Realty, an unlisted entity within the Adani Group.

  • Indian Railway Finance Corp is rising as it emerges as the lowest bidder to finance Rs 3,167 crore for the Banhardih Coal Block development in Jharkhand. The project will be undertaken by Patratu Vidyut Utpadan Nigam, a joint venture (JV) between NTPC and Jharkhand Bijli Vitran Nigam.

  • Sula Vineyards' revenue declines marginally by 0.7% YoY to Rs 217.3 crore in Q3FY25. However, wine tourism revenue grows 11.5% YoY. It features in a screener of stocks with rising net cash flow and cash from operating activities.

  • Aether Industries rises as it amends its supply agreement with Baker Hughes. The deal finalizes volume and pricing for two products exclusively manufactured by its subsidiary, Aether Specialty Chemicals.

  • According to Trendlyne’s shareholding data, mutual funds substantially raised their stake in One 97 Communications (Paytm) during Q3FY25, reaching an all-time high. By the end of December 2024, 27 mutual funds held an 11.2% stake in Paytm, amounting to 7.1 crore shares. This represents a significant increase from the 7.9% stake held in Q2FY25.
  • Delta Corp's revenue rises marginally by 0.4% YoY to Rs 235.3 crore in Q3FY25. Net profit grows 3.6% YoY to Rs 35.7 crore, helped by lower raw material and depreciation & amortization expenses. The company appears in a screener of stocks with net profit increasing over the past two quarters.

  • Welspun Corp rises sharply as it signs a memorandum of understanding (MoU) with Saudi Aramco to set up a 3.5 lakh MT per annum longitudinal submerged arc welding (LSAW) pipe manufacturing unit in Saudi Arabia.

  • Shoppers Stop rises sharply as its revenue rises 11.5% YoY to Rs 1,379.5 crore in Q3FY25. Net profit surges 41.7% YoY to Rs 52.2 crore, helped by inventory destocking. The company features in a screener of stocks with increasing net profit and profit margin (QoQ).

  • Nuvama Research expects FTSE to raise Adani Wilmar's weight in the index during its rebalancing today, following the offer for sale by its promoter. This could result in passive inflows of $25 million (approximately Rs 206 crore), equivalent to 7.8 million shares or 1.7 days of trading impact. The research highlights that trading volume mainly drives such events, not just price movements.

  • Aditya Birla Fashion and Retail's board of directors approves raising Rs 2,400 crore through a qualified institutional placement (QIP) and a preferential issue of 8.1 crore shares. The board sets the issue price at Rs 272.4 for the QIP and Rs 317.5 for the preferential issue.

  • Adani Green Energy rises sharply as it expands its operational renewable capacity to 11,666.1 MW. This follows the commissioning of a 57.2 MW wind power project in Gujarat under its wind-solar hybrid initiative, operational from January 15.

  • Angel One is rising as its net profit grows 8.1% YoY to Rs 281.5 crore in Q3FY25, driven by a reduction in fees & commission expenses. Revenue increases 19.1% YoY to Rs 1,263.8 crore, led by improvements in the active client base, number of orders, and average daily turnover (ADTO). It appears in a screener of stocks with a decrease in provisions in recent results.

  • HCL Technologies is rising as its Q3FY25 net profit grows 8.4% QoQ to Rs 4,591 crore, beating Forecaster estimates by 0.3%. Revenue increases 3.6% QoQ to Rs 30,367 crore, helped by improvements in the IT & business services, engineering & R&D services, and HCL Software segments. It features in a screener of stocks near their 52-week highs with significant volumes.

  • Markets are up today morning. Nifty 50 was trading at 23,225.45 (49.4, 0.2%), BSE Sensex was trading at 76,882.06 (382.4, 0.5%) while the broader Nifty 500 was trading at 21,536.80 (55.8, 0.3%).

  • Market breadth is highly positive. Of the 1,918 stocks traded today, 1,426 were gainers and 449 were losers.

Riding High:

Largecap and midcap gainers today include Thermax Ltd. (4,014.90, 7.5%), Phoenix Mills Ltd. (1,656.90, 5.5%) and FSN E-Commerce Ventures Ltd. (172.77, 4.8%).

Downers:

Largecap and midcap losers today include Central Bank of India (51.32, -7.3%), Indian Overseas Bank (49.91, -7.2%) and UCO Bank (42.41, -6.3%).

Crowd Puller Stocks

23 stocks in BSE 500 are trading on high volumes today.

Top high volume gainers on BSE included Newgen Software Technologies Ltd. (1,755.90, 11.5%), Devyani International Ltd. (193.29, 8.4%) and Alok Industries Ltd. (20.88, 8.1%).

Top high volume losers on BSE were Central Bank of India (51.32, -7.3%), Cello World Ltd. (669, -2.3%) and Birla Corporation Ltd. (1,155.20, -1.8%).

Vardhman Textiles Ltd. (474.80, 3.0%) was trading at 51.5 times of weekly average. Shoppers Stop Ltd. (625.10, 0.8%) and Welspun Living Ltd. (150.99, 2.7%) were trading with volumes 17.3 and 13.9 times weekly average respectively on BSE at the time of posting this article.

BSE 500: highs, lows and moving averages

1 stock took off, crossing 52 week highs, while 9 stocks hit their 52 week lows.

Stock touching their year highs included - Newgen Software Technologies Ltd. (1,755.90, 11.5%).

Stocks making new 52 weeks lows included - Asian Paints Ltd. (2,229.70, -0.5%) and Kansai Nerolac Paints Ltd. (243, -0.2%).

25 stocks climbed above their 200 day SMA including Phoenix Mills Ltd. (1,656.90, 5.5%) and Zomato Ltd. (243.90, 4.4%). 10 stocks slipped below their 200 SMA including Kalyan Jewellers India Ltd. (555.10, -6.9%) and Bajaj Finserv Ltd. (1,671.65, -2.4%).

Trendlyne Marketwatch
Trendlyne Marketwatch
13 Jan 2025
Market closes lower, GR Infra secures an order worth Rs 1,947 crore from MSRDC
By Trendlyne Analysis

Nifty 50 closed at 23,085.95 (-345.6, -1.5%), BSE Sensex closed at 76,384.73 (-994.2, -1.3%) while the broader Nifty 500 closed at 21,243.45 (-555.6, -2.6%). Market breadth is sharply down. Of the 2,446 stocks traded today, 196 were on the uptick, and 2,223 were down.

Indian indices closed lower, with the benchmark Nifty 50 index closing at 23,086 points. The Indian volatility index, Nifty VIX, rose 7.2% and closed at 16 points. The market declined after the US imposed sanctions against producers, insurers, and vessels dealing in Russian crude.

Nifty Smallcap 100 and Nifty Midcap 100 closed in the red, tracking the benchmark index. Nifty Media and Nifty Realty were among the worst-performing indices of the day. According to Trendlyne’s sector dashboard, Fertilizers emerged as one of the worst-performing sector of the day, with a fall of 6%.

European indices are trading lower, except Russia’s RTSI and MOEX indices, trading 1.6% higher each. Major Asian indices closed in the red. US index futures are trading lower, indicating a cautious start to the trading session in anticipation of the inflation data set to be released on Wednesday.

  • Money flow index (MFI) indicates that stocks like PTC Industries, Lloyds Metals & Energy, SRF, and Vijaya Diagnostic Centre are in the overbought zone.

  • Puravankara's customer collections from the real estate business grow by 6% YoY to Rs 993 crore Q3FY25. The company achieves pre-sales of Rs 1,265 crore, 2% higher than Q3FY24.

  • Afcom Holdings secures a long-term contract with Etihad Airways to operate regular flights for cargo between Chennai and Male.

  • GR Infraprojects emerges as the lowest bidder for a contract worth Rs 1,947 crore from Maharashtra State Road Development Corp (MSRDC) to construct the access-controlled Pune Ring Road from Sonori to Garade. The company will undertake the project on an engineering, procurement, and construction (EPC) basis and expects to complete it in the next three years.

  • Sharekhan selects SBI as its top pick for 2025. The brokerage has given the stock a 'Buy' rating with a target price of Rs 975. It expects advances to grow by 13% YoY, and projects net interest margins (NIMs) to remain slightly lower QoQ. The brokerage also anticipates that SBI's asset quality will remain broadly stable in Q3FY25.

  • Interarch Building Products bags two orders worth Rs 221 crore from Tata Semiconductor Assembly & Testing and Agratas Energy Storage Solutions. The Tata Semiconductor order is for its semiconductor facility in Assam, while the Agratas Energy order is to set up its lithium-ion battery manufacturing unit in Gujarat.

  • Indraprastha Gas falls as its board appoints Sukhmal Kumar Jain as the company's new Chairman, succeeding RK Jain, effective January 14.

  • NBCC (India) signs a memorandum of understanding (MoU) with Sarkari Awas Nirman Avam Vitt Nigam to develop 588 acres of land in Lucknow for mixed use. Under Phase 1 of the project, NBCC will develop 50 acres of land valued at ~Rs 3,500 crore.

  • Waaree Renewable Technologies falls 20% after Dilip Panjwani tendered his resignation as chief financial officer (CFO), citing personal reasons. Exchanges have put the securities of Waaree Renewable Tech under the long-term ASM (Additional Surveillance Measure) framework to caution investors about high volatility in share prices.

  • Brigade Enterprises signs a memorandum of understanding (MoU) with Technopark to develop a World Trade Centre and a business hotel in Thiruvananthapuram. The company plans to invest ~Rs 1,500 crore in Kerala's IT infrastructure in coming years.

  • Varroc Engineering receives approval from the National Company Law Tribunal (NCLT) to merge its subsidiary, Varroc Polymers with itself.

  • Ola Electric Mobility falls as the Central Consumer Protection Authority (CCPA) seeks additional documents to investigate alleged consumer rights violations, misleading advertisements, and unfair trade practices following a show-cause notice on October 8, 2024.

  • Adani Wilmar falls over 6%, continuing its decline from Friday. Its promoter, Adani Commodities, announced a stake sale via an offer for sale (OFS) route on January 10, 2025, at a floor price of Rs 275. Over the past two days, the edible oil company's stock has dropped by over 17%.

  • ICICI Lombard General Insurance receives an income tax refund of Rs 174.6 crore from the Income Tax (IT) Department for FY13 and FY16-18.

  • Poly Medicure forms a joint venture with AMPIN C&I Power to establish a solar power project in Haryana. The project will serve as a captive power source for Poly Medicure's facility, with AMPIN holding 74% and Poly Medicure 26%.

  • Motilal Oswal maintains its 'Buy' call on Tata Consultancy Services with a target price of Rs 5,000 per share. This indicates a potential upside of 16.4%. The brokerage believes the company's recovery in discretionary client spending and strengthening of the US economy will help in revenue growth. It expects the firm's revenue to grow at a CAGR of 7.1% over FY25-27.

  • HDFC AMC to release its quarterly results on January 14. Motilal Oswal anticipates a revenue growth of 35.7% YoY, with EBITDA expected to rise by 41.1% YoY. The net profit is projected to increase by 23.9% YoY, reaching Rs 606.7 crore. The brokerage expects equity assets under management (AUM) to continue its growth trend, driven by improved fund performance, though it anticipates a sequential decline in yields.

  • JSW Energy's subsidiary, JSW Neo Energy, acquires three special purpose vehicles (SPVs) with a total capacity of 125 MW from Hetero Group at an enterprise value of Rs 630 crore.

  • Standard Glass Lining Technology’s shares debut on the bourses at a 22.9% premium to the issue price of Rs 140. The Rs 410.1 crore IPO received bids for 183.2 times the total shares on offer.

  • Avenue Supermarts falls sharply as its net profit misses Forecaster estimates by 16% despite growing 4.8% YoY to Rs 723.7 crore in Q3FY25. Revenue rises by 17.6% YoY to Rs 15,996.7 crore, helped by new store additions. It appears in a screener of stocks near their 52-week lows.

  • Indian oil companies such as HPCL and BPCL witness a decline of over 2% as Brent crude prices surge above $81 per barrel, reaching their highest level in over four months. This increase comes amid expectations that broader US sanctions will impact Russian crude exports to major buyers like China and India. Since January 8, Brent and WTI have risen by more than 6%, with the surge following the imposition of expanded US Treasury sanctions on Russian oil.

  • Just Dial is plunging as its net profit declines by 14.8% QoQ to Rs 131.3 crore in Q3FY25, missing Forecaster estimates by 8.4%. Revenue falls by 8.5% QoQ to Rs 364.7 crore due to a reduction in total traffic during the quarter. It shows up in a screener of stocks with high promoter pledges.

  • Waaree Energies rises as it signs a share purchase agreement with Enel Green Power Development to acquire a 100% stake in its subsidiary, Enel Green Power India for up to Rs 792 crore.

  • Godrej Properties launches its first premium residential project in Hyderabad, Godrej Madison Avenue. The project offers 12 lakh sq. ft. of saleable area with 3 and 4 BHK apartments, estimated at Rs 1,300 crore in booking value.

  • PCBL falls sharply as its net profit declines 37.1% YoY to Rs 93.1 crore in Q3FY25 due to higher raw material prices, employee benefits, and finance costs. However, revenue grows by 21.5% YoY to Rs 2,021.1 crore, driven by improvement in the carbon black and chemicals segments. It appears in a screener of stocks with declining return on equity (RoE) over the past two years.

  • Gloom in markets in early trading. Nifty 50 was trading at 23241.70 (-189.8, -0.8%) , BSE Sensex was trading at 76582.18 (-796.7, -1.0%) while the broader Nifty 500 was trading at 21564.75 (-234.3, -1.1%)

  • Market breadth is sharply down. Of the 2030 stocks traded today, 291 were on the uptrend, and 1695 went down.

Riding High:

Largecap and midcap gainers today include Aditya Birla Capital Ltd. (169.84, 1.3%), Biocon Ltd. (365.20, 1.2%) and Axis Bank Ltd. (1,049.30, 0.8%).

Downers:

Largecap and midcap losers today include Adani Wilmar Ltd. (262, -10%), Macrotech Developers Ltd. (1,165.30, -9.2%) and Rail Vikas Nigam Ltd. (357.95, -9.0%).

Volume Shockers

22 stocks in BSE 500 are trading on high volumes today.

Top high volume gainers on BSE included Prism Johnson Ltd. (162.18, 7.2%), Piramal Pharma Ltd. (232.65, 5.2%) and Crisil Ltd. (5,806.35, 2.3%).

Top high volume losers on BSE were Just Dial Ltd. (899.30, -13.1%), PCBL Ltd. (351.85, -10.0%) and Adani Wilmar Ltd. (262, -10%).

Happiest Minds Technologies Ltd. (718.50, 1.7%) was trading at 7.2 times of weekly average. Aditya Birla Capital Ltd. (169.84, 1.3%) and KEI Industries Ltd. (3,974.95, -4.8%) were trading with volumes 5.2 and 5.2 times weekly average respectively on BSE at the time of posting this article.

BSE 500: highs, lows and moving averages

2 stocks hit their 52 week highs, while 80 stocks were underachievers and hit their 52 week lows.

Stocks touching their year highs included - HCL Technologies Ltd. (1,989.40, -0.3%) and Krishna Institute of Medical Sciences Ltd. (617.85, -4.9%).

Stocks making new 52 weeks lows included - ACC Ltd. (1,859.45, -3.7%) and Asian Paints Ltd. (2,252.65, -2.9%).

3 stocks climbed above their 200 day SMA including Tata Consultancy Services Ltd. (4,291.10, 0.6%) and Indian Renewable Energy Development Agency Ltd. (199.88, -0.6%). 57 stocks slipped below their 200 SMA including PCBL Ltd. (351.85, -10.0%) and Macrotech Developers Ltd. (1,165.30, -9.2%).

logo
The Baseline
10 Jan 2025
Five Interesting Stocks Today - January 10, 2025
By Trendlyne Analysis

1. Titan Company:

This gems and jewellery major has risen by 1.5% over the past week, outperforming its industry by 4.1%. This comes after Titan reported a 24% YoY growth in revenue in its Q3FY25 business update.

The jewellery segment (which contributes over 87% of the total revenue) grew by 25% YoY, driven by strong festive demand. Plain gold jewellery sales jumped 24% YoY due to robust festive and wedding purchases over October-December despite higher gold prices, while gold coin sales surged 48% YoY.

Analysts believe that jewellery consumption remained strong due to rising gold prices, more auspicious days, and a shift from unorganised to organised trade after a 900 bps gold import duty cut to 6% (during the FY25 Union Budget). The company’s peer Kalyan Jewellers has also reported healthy revenue growth in Q3FY25, with a 39% YoY rise. According to Trendlyne’s Forecaster, Titan’s revenue is expected to grow by 16.1% YoY in Q3FY25.

Meanwhile, the company added 69 stores on a net basis during the quarter, taking its retail store count to 3,240. Titan has a market share of 8% in the Indian jewellery market and has been working on expanding its retail footprint. It also aims to triple volumes in emerging segments like wearables, women’s bags and ethnic wear by FY27. It opened an exclusive store for its bags and accessories brand, IRTH, in Chennai, as part of its expansion plans in South India. Commenting on this, Manish Gupta, CEO of the Fragrances and Fashion Accessories Division, said, “We aim to achieve Rs 1,000 crore in revenue by FY26-27 from our IRTH and Fastrack bags divisions”.

InCred Equities gives an ‘Add’ rating on Titan Co with a target price of Rs 3,600. The brokerage remains positive on the company but expects margin pressures from higher gold prices and diamond price volatility. It expects EBITDA margins to contract by 105 bps YoY to 10% in Q3FY25.

2. Manappuram Finance:

This gold loan company’s share price jumped over 6% before paring its gains amid profit booking by investors. This surge followed the company’s announcement that the RBI had lifted its ban on new loans and disbursements by its subsidiary, Asirvad Micro Finance. The RBI had slapped this ban on Asirvad over two months ago on October 22, after it found “material supervisory concerns and non-compliance issues”.

Manappuram’s stock fell by over 13% after the ban was imposed and made a 52-week low in the days that followed. The removal of this ban is a significant development for the company, as its micro-finance business contributes around 30% to its total revenue. The other 70% of the company’s revenue comes from gold loans. 

The company's consolidated AUM (assets under management) jumped by 17.4% on a YoY basis in Q2. The gold loan segment has experienced remarkable growth over the past year, driven by higher-than-normal interest rates on unsecured loans. Bloomberg columnist Andy Mukherjee, writes that loans against gold jewellery have risen in India by 56.2% annually. In Q3, Forecaster expects revenue growth for Manappuram of 14.2%, with net profit growth of 8% on a YoY basis.

V P Nandakumar, MD and CEO, said, “The micro-finance sector is facing (collection-related) challenges in certain geographies.” Due to this, the company added around 5,000 new loan officers in Q2. He also said that he expects net interest margins to fall as operating expenses rise.

Motilal Oswal retains a 'Hold' rating on the stock with an upgraded target price of Rs 205. The brokerage anticipates a gradual recovery in Asirvad’s microfinance (MFI) and gold loan segments. However, it predicts that credit costs will remain high over the next two to three quarters due to industry-wide pressures. Currently, the stock is in the PE Buy Zone, trading at a relatively cheaper valuation than its historical PE.

3. Dabur India:

ThisFMCG producer declined 3.8% on January 6 following theannouncement of its Q3FY25 business update. Dabur India expects low single-digit (~1-5%) revenue growth due to weak demand in segments like Health Care, impacted by a delayed winter, and in Beverages, as consumersshift from non-carbonated to carbonated drinks. Higher-priced juices are seeing the biggest impact.

Management noted that rural demand for FMCG outpaced urban demand, contributing around 4-8% growth in the home & personal care (HPC) segment. Dabur expects its culinary brands to deliver double-digit growth, supported by brands like 'Homemade Cooking Pastes & Purees' and 'Badshah Spices.'

InQ2FY25, the company reported a revenue decline of 5.5% YoY to Rs 3,028.6 crore, with net profit falling 17.5% YoY to Rs 425 crore. This underperformance was due to heavy rainfall, floods, and high food inflation, which slowed down consumption. Dabur Indiareduced the inventory days of its general trade partners from 30 days to 21 days in Q2, to tackle challenges from alternative channels like modern trade, e-commerce, and quick commerce. The company aimed to reduce this by 19 days by the end of December ‘24. According toTrendlyne’s Forecaster estimates, the company’s revenue is expected to grow by 5.8% YoY in Q3FY25. 

Mohit Malhotra, CEO of Dabur India,said, “We expect the Home Care portfolio to grow in double digits going forward in the future, taking up the portfolio from Rs 700 crore to around Rs 1,000 crore in 2 to 3 years.” To achieve this, Dabur is premiumizing and expanding its home care range, introducing Odonil (room air freshener) in gel pockets, diffusers, and premium air fresheners, and launching Odomos (mosquito repellent) in a liquid vaporizer format. The recentacquisition of hair oil brand Sesa marks Dabur’s entry into the premium Ayurvedic hair oil market, in line with its strategy to diversify and expand.

Still, analysts are pessimistic. Following the business update, Citimaintained its ‘sell’ rating on Dabur India and lowered its target price to Rs 510. The brokerage expects a 2.5% YoY revenue growth in Q3FY25, citing weak performance in healthcare and beverages, rising costs, and shifting consumer preferences as key challenges.

4. Zydus Lifesciences:

This pharma company's stock rose by 1.4% over the past week after it signed an agreement with CVS Caremark, a US healthcare solutions provider, on January 7. The agreement also adds the ZituvioTM range - Sitagliptin and combination tablets - to CVS' list of medicines for type 2 diabetes treatment. 

On the same day, the US FDA accepted the New Drug Application (NDA) for CUTX-101, a potential treatment for Menkes disease, and assigned it priority review. The application was filed by Sentynl Therapeutics, the US subsidiary of Zydus. Menkes disease is a rare pediatric condition with no FDA-approved treatment, and often leads to death in infants. The CUTX-101 clinical trials showed promising results, with early-treated patients having an 80% lower death risk. The Menkes disease market, valued at approximately $8 million at the end of 2023, is expected to grow 5.9% annually through 2034.

Following the news, Nomura upgraded Zydus Life to ‘Buy’ from ‘Hold’ and raised its price target to Rs 1,140, indicating an upside of 13.5%. The brokerage also increased earnings estimates due to higher contributions from the Sitagliptin drug, used to regulate high blood sugar. They believe the drug’s market opportunity, estimated between $300-500 million, could provide Zydus with an annual revenue boost of $100-150 million. However, they anticipate a 5% decline in US revenues in FY26.

In Q2FY25, the company’s revenue increased 19.9% YoY to Rs 5,237 crore, driven by improvements in the US formulation (up 30%) and Indian formulation (up 9%). Its net profit rose 20.5% YoY to Rs 865.8 crore during the quarter. For Q3FY25, Trendlyne’s Forecaster estimates profit to surge 14.9% YoY, with a revenue growth of 17.8%.

Managing Director Sharvil Patel mentioned that Zydus is focusing on expanding its portfolio in the US by targeting high-value products that offer better returns and margins. This involves launching limited-competition products and exploring in-licensing opportunities for niche, high-value products. He added, “We anticipate topline growth in the high teens (15-17%) and maintain our FY25 margin guidance of 27%, with an expected improvement of 100-150 basis points over last year.”

5. Reliance Industries:

This refineries & petro-products company has declined by over 4% in the past month. The company has reportedly raised $3 billion (approximately Rs 24,900 crore) from a consortium of 11 banks, marking its largest borrowing deal in nearly two years. The five-year loan, finalized last month, was set at 120 bps above the three-month Secured Overnight Financing Rate (SOFR), with $450 million (around Rs 3,700 crore) denominated in Japanese yen. It is also reported that the company is gearing up for substantial loan repayments in 2025.

The company posted a nominal 0.3% YoY increase in revenue for Q2FY25. However, its net profit declined by 4.8% to Rs 16,563 crore due to a decline in EBIT of the Oil-to-Chemical(O2C) segment. The Trendlyne Forecaster estimates the company’s revenue to rise by 2.9% and the net profit to rise by 4.8% Q3FY25. Morgan Stanley expects the company's refining segment to grow on the back of increasing global demand. It appears in a screener of stocks where mutual funds have increased holdings in the past month.

Mukesh Ambani, chairman & MD of the company, said, “Jio and Retail are expected to double their revenues and EBITDA in the next 3-4 years. I see immense growth potential in our media business. I foresee our New Energy business becoming as big and profitable over the next 5-7 years, as our O2C business which we had built over the past 40 years.” 

Global brokerage firm Jefferies points out that while Reliance lagged behind the Nifty 50 index by 15% in 2024, primarily due to concerns about its retail business's medium-term growth and weak earnings growth for the year, the company’s retail segment is expected to see mid-teen growth going forward. Additionally, improved profitability is anticipated in the Oil-to-Chemicals (O2C) segment by FY26. Jefferies also notes the potential initial public offering (IPO) of Reliance Jio, the company’s telecom arm in FY26.

Geojit has maintained Reliance Industries at a ‘Buy’ rating as it expects the recent tariff hikes and ongoing technology advancements to strengthen Jio's customer base, supporting its growth momentum. The brokerage also says that although the recent tariff hikes led to some SIM consolidation and a higher churn rate, the management expects the full impact of the hikes to be reflected in the earnings over the next 2-3 quarters. With a target price of Rs 1,516, the stock has a potential upside of over 22%.

Trendlyne's analysts identify stocks that are seeing interesting price movements, analyst calls, or new developments. These are not buy recommendations.

Trendlyne Marketwatch
Trendlyne Marketwatch
10 Jan 2025
Market closes lower, CESC revenue rises 9.8% YoY to Rs 3,561 crore in Q3FY25'
By Trendlyne Analysis

Nifty 50 closed at 23,431.50 (-95, -0.4%), BSE Sensex closed at 77,378.91 (-241.3, -0.3%) while the broader Nifty 500 closed at 21,799 (-247.6, -1.1%). Market breadth is highly negative. Of the 2,397 stocks traded today, 358 were in the positive territory and 2,020 were negative.

Indian indices closed lower, with the benchmark Nifty 50 index closing at 23,440 points. The Indian volatility index, Nifty VIX, rose 1.7% and closed at 14.9 points. Tata Consultancy Services closed deep in the green as its net profit grows 3.4% QoQ to Rs 12,380 crore in Q3FY25, revenue decreases marginally QoQ to Rs 63,973 crore.

Nifty Smallcap 100 and Nifty Midcap 100 closed in the red. Nifty Media and BSE Power closed lower. According to Trendlyne’s sector dashboard, Software & Services emerged as the best-performing sector of the day, with a rise of 2.3%.

European indices are trading mixed. Major Asian indices closed mixed. US index futures are trading lower, indicating a cautious start to the trading session in anticipation of the unemployment data set to be released later today.

  • Relative strength index (RSI) indicates that stocks like PTC Industries, SRF, Lloyds Metals & Energy, and Navin Fluorine International are in the overbought zone.

  • CESC falls sharply as its net profit declines 5.7% YoY to Rs 265 crore in Q3FY25. Its revenue rises 9.8% YoY to Rs 3,561 crore but misses Forecaster estimates by 2.7%. The company appears in a screener of stocks with profits declining from last two quarters.

  • Shilpa Medicare receives marketing authorization in Portugal, Europe, for Tadalafil Orodispersible Films (20 mg), used to treat erectile dysfunction. The European market for this drug is valued at approximately $400 million (around Rs 3,437.2 crore).

  • Indegene enters a partnership with CliniOps to speed up the process of clinical trials. Under the partnership, Indegene will provide its expertise in patient recruitment and data services, using CliniOps' Unified platform to streamline data collection.

  • IndusInd Bank declines over 4% as Goldman Sachs downgrades its rating to 'Neutral' with a lower target price of Rs 1,090. The brokerage anticipates consolidation in the bank's credit growth and consumer retail for households due to increased leverage. It adds that higher credit costs are a concern, as various loan segments are experiencing a credit downcycle.

  • Delta Corp rises sharply as the Supreme Court stays GST proceedings on Rs 1.1 lakh crore show cause notices to online gaming firms, providing relief until the apex court reaches a final decision.

  • Syrma SGS Technology partners with MSI as its manufacturing partner in India to produce laptops for the Indian market. Under this partnership the company will assemble laptops for MSI at its Chennai facility.

  • Geojit BNP Paribas upgrades PVR INOX to 'Buy' from 'Accumulate' but lowers the target price to Rs 1,437 per share. This indicates a potential upside of 24.9%. The brokerage expects the company's profitability to improve, led by festive demand and the release of blockbuster and franchise movies combined with its initiative to revive footfalls and reduce costs. It expects the firm's revenue to grow at a CAGR of 9.5% over FY25-26.

  • Sundararaman Ramamurthy, CEO of BSE, believes India’s record capital-raising momentum will continue in 2025, driven by a strong pipeline of companies planning to go public. He notes that over 90 companies have already submitted their draft prospectus to the regulator, aiming to raise an estimated Rs 1 lakh crore ($11.7 billion) this year.

  • Hindustan Copper announces the reopening of the Rakha Copper Mine in Jharkhand after over two decades. The mine, along with a new Chapri underground mine and concentrator plant, will be developed by South West Mining (SMWL) under a Rs 2,700 crore project.

  • Aditya Birla Fashion and Retail's board of directors schedules a meeting for January 15 to consider a proposal to raise funds via a qualified institutional placement (QIP) of equity shares or other methods.

  • Neogen Chemicals is falling as the National Company Law Tribunal (NCLT) approves the merger of its subsidiary, Buli Chemicals India, with itself.

  • The National Restaurant Association of India (NRAI) reportedly opposes e-commerce platforms Zomato and Swiggy's "private labelling" efforts as they venture into quick commerce food delivery via separate apps. NRAI plans to file complaints with regulators, claiming that these practices violate fair competition principles and pose a threat to restaurants nationwide.

  • Phoenix Mills rises as its consumption sales rise 21% YoY to Rs 3,998 crore in Q3FY25, driven by a strong festive season performance at PMC Mumbai, PMC Pune, and Phoenix Palassio. Meanwhile, 9MFY25 consumption grows 23% YoY to Rs 10,504 crore.

  • Sona BLW Precision Forgings is rising as it signs a memorandum of understanding (MoU) with NMICPS Technology Innovation Hub on Autonomous Navigation Foundation at IIT Hyderabad (TIHAN-IITH) during CES 2025 in Las Vegas, USA. The agreement involves the development of connected, autonomous, and electric technologies for autonomous ground vehicles (AGVs), drones, and electric vertical take-off and landing vehicles (eVTOLs).

  • Indian Overseas Bank is falling as it reportedly plans to sell its non-performing assets (NPA) portfolio, consisting of 46 non-performing loans, for Rs 11,500 crore, through an e-auction.

  • Macquarie initiates coverage on IRCTC with an 'Outperform' rating and a target price of Rs 900. The brokerage highlights the company has a monopoly in Indian Railways' e-ticketing and catering services, offering a dominant market position. It sees the potential for 2x returns, driven by IRCTC's strategic role in India's railways and high-margin business model.

  • Adani Total Gas announces a 20% rise in administered price mechanism (APM) gas allocation, effective January 16, following communication from GAIL (India). This update reverses earlier reductions announced in October and November 2024.

  • Vodafone Idea is falling as its board of directors approves allotting 169.3 crore shares to its promoters, Omega Telecom Holdings and Usha Martin Telematics, for Rs 1,910 crore.

  • Adani Wilmar falls sharply as its promoter, Adani Commodities, announces plans to sell 17.5 crore shares (13.5% stake) through an offer for sale (OFS) on the stock exchange at a floor price of Rs 275 per share.

  • Jefferies expects CY25 to be a key year for earnings growth in the contract development and manufacturing organization (CDMO) sector. However, it also warns that potential slippages could impact the sector's high valuations. The brokerage names Piramal Pharma its top pick and retains a 'Buy' rating with a target price of Rs 310. It upgrades Syngene Int. to a 'Hold' rating and downgrades Gland Pharma to 'Underweight' with target prices of Rs 890 and Rs 1,630, respectively.

  • Polyplex Corp's board of directors approves the capacity expansion of its biaxially oriented polyethylene terephthalate (BOPET) film manufacturing plant by 52,400 million tonnes per annum (MTPA) with a capex of $65 million (~ Rs 558 crore).

  • Tata Elxsi plunges to its 52-week low of Rs 5,929.9 per share as its net profit declines by 13.3% QoQ to Rs 199 crore in Q3FY25. Revenue decreases by 4% QoQ to Rs 979 crore, impacted by the software development & services and system integration & support services segments. It appears in a screener of stocks with a QoQ degrowth in revenue, profits, and operating profit margin in recent results.

  • Ceinsys Tech rises to its 5% upper limit as it receives a letter of intent (LoI) for an order worth Rs 381.2 crore from Vidarbha Irrigation Development Corporation (VIDC). The order involves a detailed survey, hydrology study, design, and estimation of key infrastructure such as canals, pipelines, tunnels, and other structures for the Wainganga-Nalganga River Link Project. The project spans districts in Maharashtra, including Nagpur, Wardha, and Yavatmal.

  • Tata Consultancy Services is rising as its net profit grows 3.4% QoQ to Rs 12,380 crore in Q3FY25, driven by lower employee benefit expenses. Revenue decreases marginally QoQ to Rs 63,973 crore. The company appears in a screener of stocks with improving return on equity over the past two years.

  • Nifty 50 was trading at 23,561.05 (34.6, 0.2%), BSE Sensex was trading at 77,682.59 (62.4, 0.1%) while the broader Nifty 500 was trading at 22,015.95 (-30.6, -0.1%).

  • Market breadth is moving down. Of the 1,930 stocks traded today, 510 were gainers and 1,371 were losers.

Riding High:

Largecap and midcap gainers today include Tata Consultancy Services Ltd. (4,265.65, 5.6%), LTIMindtree Ltd. (6,124.40, 4.9%) and Tech Mahindra Ltd. (1,705.60, 3.8%).

Downers:

Largecap and midcap losers today include Adani Wilmar Ltd. (291.10, -10%), General Insurance Corporation of India (427.50, -8.0%) and Indian Renewable Energy Development Agency Ltd. (201.15, -6.9%).

Volume Rockets

14 stocks in BSE 500 are trading on high volumes today.

Top high volume gainers on BSE included Ramkrishna Forgings Ltd. (957.10, 5.9%), Tata Consultancy Services Ltd. (4,265.65, 5.6%) and Anand Rathi Wealth Ltd. (4,154.35, 5.3%).

Top high volume losers on BSE were Adani Wilmar Ltd. (291.10, -10%), Tata Elxsi Ltd. (6,000.60, -6.8%) and Piramal Pharma Ltd. (221.25, -6.7%).

Indian Railway Catering & Tourism Corporation Ltd. (779.15, 2.0%) was trading at 7.2 times of weekly average. Aadhar Housing Finance Ltd. (422.95, 0.1%) and Sterling and Wilson Renewable Energy Ltd. (447.55, 2.0%) were trading with volumes 6.1 and 4.6 times weekly average respectively on BSE at the time of posting this article.

BSE 500: highs, lows and moving averages

3 stocks overperformed with 52 week highs, while 35 stocks hit their 52 week lows.

Stocks touching their year highs included - HCL Technologies Ltd. (1,995.10, 3.1%), Lloyds Metals & Energy Ltd. (1,449.65, 1.0%) and PTC Industries Ltd. (17,083.15, -1.8%).

Stocks making new 52 weeks lows included - Bank of India (94.27, -4.5%) and Can Fin Homes Ltd. (679.35, -2.0%).

7 stocks climbed above their 200 day SMA including Tata Consultancy Services Ltd. (4,265.65, 5.6%) and Procter & Gamble Health Ltd. (5,250.25, 3.5%). 48 stocks slipped below their 200 SMA including Indian Renewable Energy Development Agency Ltd. (201.15, -6.9%) and Techno Electric & Engineering Company Ltd. (1,399.05, -5.8%).